PAHC Phibro Animal Health Corporation
Healthcare$33.68+1.26%ClosedMarket Cap: $1.37B
As of 2026-05-26
Valuation
P/E (TTM)
24.50
PEG
0.07
P/B
3.73
P/S
0.90
EV/EBITDA
8.85
DCF Value
$-13.89
FCF Yield
0.9%
Div Yield
1.4%
Margins & Returns
Gross Margin
32.5%
Operating Margin
12.3%
Net Margin
6.3%
ROE
29.5%
ROA
6.6%
ROIC
11.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $383.5M | 32.6% | $48.0M | $24.0M | $— | $0.12 |
| Q2 null | $373.9M | 35.5% | $54.4M | $27.5M | $— | $0.12 |
| Q1 null | $363.9M | 32.9% | $47.9M | $26.5M | $— | $0.12 |
| Q4 null | $378.7M | 29.0% | $33.7M | $17.2M | $— | $0.12 |
| FY null | $1.30B | 30.9% | $110.5M | $48.3M | $— | $0.48 |
| Q3 null | $347.8M | 30.1% | $33.5M | $20.9M | $— | $0.12 |
| Q2 null | $309.3M | 32.9% | $25.5M | $3.2M | $— | $0.12 |
| Q1 null | $260.4M | 32.1% | $17.7M | $7.0M | $— | $0.12 |
| Q4 null | $273.2M | 31.9% | $18.4M | $752.0K | $— | $0.12 |
| FY null | $1.02B | 30.8% | $53.3M | $2.4M | $— | $0.48 |
| Q3 null | $263.2M | 30.2% | $19.9M | $8.4M | $— | $0.12 |
| Q2 2024 | $249.9M | 31.5% | $15.7M | $1.3M | $0.03 | $0.12 |